FindTrial
Sign In

Role of key hole diagnosis (staging laparoscopy) and cell type (cytology) in diagnosis of stomach and food pipe (oesophageal) cancer.

Staging laparoscopy and cytology and its implication in management of locally advanced gastric and gastro-esophageal junction adeno-carcinoma.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/11/022174
Enrollment
50
Registered
2019-11-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C169- Malignant neoplasm of stomach, unspecified

Interventions

Intervention1: NIL: NIL

Sponsors

Department of General Surgery
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Histological confirmed diagnosis of primary gastric carcinoma (including esophagus-gastric junction). - CECT abdomen showing a clinical stage of T3-4bN0-3bM0; -Fit for radical gastrectomy or neo-adjuvant chemotherapy; -Willing to comply with protocol, and provide informed consent form.

Exclusion criteria

Exclusion criteria: -Early gastric and GE Junction tumor -Metastatic carcinoma in radiological intervention. -Carcinoma stomach with gastric outlet obstruction -GE junction Squamous cell carcinoma

Design outcomes

Primary

MeasureTime frame
To find out the efficacy of staging laparoscopy and cytology study in upstaging the cancer.Timepoint: At the end of study.—

Secondary

MeasureTime frame
To look for change in the management strategy of these patients.Timepoint: At the end of both modalities results.—

Countries

India

Contacts

Public ContactSarbjit Mohapatra

Kasturba Medical College, Manipal

gaby.rodrigues@manipal.edu9448501301

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026